FOR IMMEDIATE RELEASE
The alliance brings together regulatory architecture, commercial strategy, and executive execution to support early- and growth-stage companies.
KANSAS CITY, Mo. (June 2, 2026) — Frontier BioStrategy and Calibrate Agribusiness Consultancy today announced a strategic alliance to help ag-biological companies move from innovation to full-scale commercialization. The partnership pairs Frontier BioStrategy’s work at the strategic and architectural level, spanning regulatory architecture, commercial strategy, and product development governance, with Calibrate’s hands-on commercialization, producer engagement, channel development, and go-to-market execution.
As rising fertilizer costs, demand for cleaner food systems, and momentum behind regenerative agriculture push biologicals into the commercial spotlight, many companies still stall in the transition from product development to regulatory alignment, market access, and on-farm adoption. The alliance was formed to close that gap, giving early- and growth-stage companies integrated strategy and execution support across the commercialization lifecycle, without full-time executive overhead.
Strong commercialization starts well before launch. Regulatory strategy, product claims, technical development, and market positioning must be built together. By aligning with Calibrate, we can help companies connect that early architecture to the execution required for adoption.
Ben Cicora, Co-Founder, Frontier BioStrategy
Read the full announcement below.
Calibrate and Frontier BioStrategy Alliance — Press Release (PDF)
Working on something that touches these topics?
Most engagements begin with a 30-minute scoping conversation.